Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13290604 | 0.72 | KDM4E (0.35) | OPRM1OPRD1OPRK1KDM4EGAA | |
| SCHEMBL23559996 | 0.65 | TSHR (0.48) | OPRM1OPRD1OPRK1KDM4EGAA | |
| SCHEMBL6922492 | 0.63 | GAA (0.38) | OPRM1OPRD1OPRK1KDM4EGAA | |
| SCHEMBL6923193 | 0.63 | TSHR (0.47) | OPRM1OPRD1OPRK1KDM4EGAA | |
| SCHEMBL29290042 | 0.61 | KDM4E (0.37) | OPRM1OPRD1OPRK1KDM4EGAA | |
| SCHEMBL16487715 | 0.61 | KDM4E (0.37) | OPRM1OPRD1OPRK1KDM4EGAA | |
| SCHEMBL1710042 | 0.61 | KDM4E (0.37) | OPRM1OPRD1OPRK1KDM4EGAA | |
| SCHEMBL16306651 | 0.61 | KDM4E (0.34) | OPRM1OPRD1OPRK1KDM4EGAA | |
| SCHEMBL84808 | 0.60 | CHRNA7 (0.48) | KDM4EGAA | |
| SCHEMBL262312 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230053437-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2023-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230053437-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | CETP, NPC1, LCAT | OPRM1 4728/4885OPRD1 4726/4885OPRK1 4752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.